• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer.

作者信息

Cai D W, Mukhopadhyay T, Liu Y, Fujiwara T, Roth J A

机构信息

Department of Thoracic and Cardiovascular Surgery, University of Texas M. D. Anderson Cancer Center, Houston 77030.

出版信息

Hum Gene Ther. 1993 Oct;4(5):617-24. doi: 10.1089/hum.1993.4.5-617.

DOI:10.1089/hum.1993.4.5-617
PMID:8280799
Abstract

A retroviral vector-mediated system was established to allow efficient transduction of the wild-type p53 gene into human lung cancer cell lines H358a (deleted p53) and H322a (mutant p53). LNSX/p53 constructs incorporating p53 cDNA driven by a beta-actin promoter mediated stable integration of p53. p53 mRNA and protein were detected in these cell lines 6 months after transduction by Northern and Western blot analyses. Restoration of the wild-type p53 gene suppressed growth in the two transduced cell lines but had no effect in another transduced tumor cell line, H460a, which has an endogenous wild-type p53 gene. A high transduction efficiency was obtained in cell lines H460a, H322a, and H358a after five cycles of transduction in vitro. Mixing experiments showed that transduced cells could reduce the growth rate of nontransduced cells; this reduction may have been mediated by factors shed into the supernatant of the transduced cell cultures.

摘要

相似文献

1
Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer.
Hum Gene Ther. 1993 Oct;4(5):617-24. doi: 10.1089/hum.1993.4.5-617.
2
A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.一种逆转录病毒野生型p53表达载体可穿透人肺癌球体并通过诱导凋亡来抑制其生长。
Cancer Res. 1993 Sep 15;53(18):4129-33.
3
Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype.逆转录病毒载体介导的K-ras反义RNA导入人肺癌细胞可抑制恶性表型的表达。
Hum Gene Ther. 1993 Aug;4(4):451-60. doi: 10.1089/hum.1993.4.4-451.
4
Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.非小细胞肺癌细胞是由重组2型腺相关病毒载体介导的p53基因转移的主要靶标。
Cancer Gene Ther. 2003 Dec;10(12):898-906. doi: 10.1038/sj.cgt.7700643.
5
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.逆转录病毒介导的野生型p53基因向肺癌患者肿瘤的转移。
Nat Med. 1996 Sep;2(9):985-91. doi: 10.1038/nm0996-985.
6
Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model.逆转录病毒野生型p53表达载体在原位肺癌模型中的治疗效果。
J Natl Cancer Inst. 1994 Oct 5;86(19):1458-62. doi: 10.1093/jnci/86.19.1458.
7
A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer.一项腺病毒介导的野生型p53基因转移用于晚期非小细胞肺癌患者的I期研究。
Hum Gene Ther. 1998 Sep 20;9(14):2075-82. doi: 10.1089/hum.1998.9.14-2075.
8
Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
Cancer Gene Ther. 1995 Sep;2(3):199-205.
9
Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.CD95(Fas/APO-1)受体/配体系统在野生型p53基因转导诱导人癌细胞凋亡中的差异作用。
Oncogene. 1999 Apr 1;18(13):2189-99. doi: 10.1038/sj.onc.1202561.
10
E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis.E1B 缺失的腺病毒由于缺乏细胞凋亡而在 p53 缺陷的肺癌细胞中复制。
Oncol Rep. 2005 Nov;14(5):1155-63.

引用本文的文献

1
Therapeutic efficacy of p53 restoration in Mdm2-overexpressing tumors.在Mdm2过表达肿瘤中恢复p53的治疗效果。
Mol Cancer Res. 2014 Jun;12(6):901-11. doi: 10.1158/1541-7786.MCR-14-0089. Epub 2014 Mar 5.
2
The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.肺癌的分子基础:分子异常与治疗意义。
Respir Res. 2003;4(1):12. doi: 10.1186/1465-9921-4-12. Epub 2003 Oct 7.
3
Molecular characterization of p53 mutations in primary and secondary liver tumors: diagnostic and therapeutic perspectives.
原发性和继发性肝肿瘤中p53突变的分子特征:诊断与治疗前景
Mol Biotechnol. 2002 Jul;21(3):265-78. doi: 10.1385/MB:21:3:265.
4
Gene therapy in lung cancer.肺癌的基因治疗。
Curr Oncol Rep. 2000 Jan;2(1):64-70. doi: 10.1007/s11912-000-0012-1.
5
Introduction of wild-type p53 gene downregulates the expression of H-ras gene and suppresses the growth of bladder cancer cells.野生型p53基因的导入可下调H-ras基因的表达并抑制膀胱癌细胞的生长。
Urol Res. 1995;23(5):311-314. doi: 10.1007/BF00300019.
6
Antisense oncogene and tumor suppressor gene therapy of cancer.癌症的反义癌基因与肿瘤抑制基因治疗
J Mol Med (Berl). 1996 Apr;74(4):191-204. doi: 10.1007/BF00204749.
7
Strategies for cancer gene therapy using adenoviral vectors.使用腺病毒载体进行癌症基因治疗的策略。
J Mol Med (Berl). 1996 Apr;74(4):183-9. doi: 10.1007/BF00204748.